The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
White Papers
AHRMM19 CQO Summit White Paper entitled CQO: The Power of Clinical Integration.
Webcast
The intersection of CQO is patient care, Deborah Rey presents ten commandments you should adopt if they're not already part of your values both…
Webcast
Panelists in Part 4 of the GPO or Local/Self Contracting webcast series focus on what providers should expect from their GPO partners. In a Part 5…
On-Demand Educational Webinars
On-site supply storage is one of the core competencies of effective supply chain management, and adhering to standards and regulations is an ongoing…
Webcast
Brent Petty, executive industry consultant, Healthcare Lexmark International, discusses what forces are currently affecting health care and the pla